MARKET PULSE-Chelsea Therapeutics, Herbalife, Colgate, Garmin, Zale
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures fell on Wednesday. Dow Jones industrial average futures were down 0.04 percent at 16,101, S&P 500 futures were down 0.33 percent at 1,831.3 and Nasdaq 100 futures were down 0.22 percent at 3,666.75.
** CHELSEA THERAPEUTICS INTERNATIONAL LTD, Tuesday close $4.95, +36.16 pct premarket
The company's drug Northera, which treats a rare form of low blood pressure associated with neurological disorders such as Parkinson's disease, has won U.S. approval, the Food and Drug Administration said on Tuesday.
** SIGNET JEWELERS LTD, Tuesday close $79.27, +13.85 pct premarket
** ZALE CORP, Tuesday close $14.91, +40.17 pct premarket
Kay Jewelers parent Signet Jewelers said it would acquire smaller rival Zale Corp for $21 per share in cash, valuing the mid-tier jeweler at about $690 million.
The offer represents a premium of about 41 percent to Zale's close of $14.91 on the New York Stock Exchange on Tuesday. Continued...